PREPlab

Stop PREP to stop neurodegeneration?

We are studying the role of prolyl oligopeptidase (PREP, formerly known as POP) on disease progression and neuronal toxicity in neurodegenerative disorders with protein aggregation. These disorders involve several serious diseases such as Alzheimer’s and Parkinson’s diseases, and several more rare neurodegenerative conditions. Based on PREP inhibitors, we are developing novel and disease-modifying drug therapies to stop the neuronal death in Alzheimer's and Parkinson's diseases.
Find more about PREP research

News

Recent news from PREP lab
@MyohanenTimo

As many of you scientists are now working from home, let me take the opportunity to remind that my proofreading ser… twitter.com/i/web/status/1…

Nyt @hsfi oikeasti... Ette voi alentua roskalehtien tasolle tässä tilanteessa #covid19 #sensaatio #otsikot twitter.com/Petri2020/stat…

Kiitos muuten kaikille farmaseuteille ja proviisoreille, jotka eivät voi jäädä kotiin. Älä mene tartuttamaan työn… twitter.com/i/web/status/1…

Go @jeanttila 😊👍 #phd #defense @helsinkiuni twitter.com/AiravaaraLab/s…